Chasing exciting new developments in medicine can be a very expensive endeavor. Such is the takeaway from AstraZeneca’s announcement that a hotly anticipated clinical trial didn’t meet expectations.
from WSJ.com: Markets http://ift.tt/2vaH7m1
via https://ifttt.com/ IFTTT
No comments:
Post a Comment